Latest filings (excl ownership)
S-8
Registration of securities for employees
15 Mar 24
10-K
2023 FY
Annual report
11 Mar 24
S-8
Registration of securities for employees
21 Dec 23
8-K
LifeMD and Medifast Partner to Offer Transformative Weight Management Solution
13 Dec 23
8-K
Departure of Directors or Certain Officers
14 Nov 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Regulation FD Disclosure
10 Aug 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Departure of Directors or Certain Officers
31 Jul 23
8-K
Departure of Directors or Certain Officers
14 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
7 Jul 23
424B5
Prospectus supplement for primary offering
29 Jun 23
8-K
LifeMD Appoints William J. Febbo to its Board of Directors
22 Jun 23
8-K
Departure of Directors or Certain Officers
16 Jun 23
10-Q
2023 Q1
Quarterly report
12 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
424B5
Prospectus supplement for primary offering
27 Mar 23
8-K
LifeMD, Inc. Announces Closing of New $40 Million Credit Facility
22 Mar 23
10-K
2022 FY
Annual report
22 Mar 23
8-K
LifeMD Appoints Dr. Joan LaRovere to its Board of Directors
10 Feb 23
8-K
Entry into a Material Definitive Agreement
9 Feb 23
8-K
Departure of Directors or Certain Officers
21 Dec 22
8-K
Regulation FD Disclosure
14 Nov 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
LifeMD Appoints Bobby Jindal to the Board of Directors
20 Sep 22
8-K
Changes in Registrant's Certifying Accountant
14 Sep 22
424B3
Prospectus supplement
17 Aug 22
424B3
Prospectus supplement
17 Aug 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
EFFECT
Notice of effectiveness
8 Jul 22
POS AM
Prospectus update (post-effective amendment)
1 Jul 22
8-K
Departure of Directors or Certain Officers
22 Jun 22
10-Q
2022 Q1
Quarterly report
13 May 22
EFFECT
Notice of effectiveness
3 May 22
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
POS AM
Prospectus update (post-effective amendment)
28 Mar 22
10-K
2021 FY
Annual report
7 Mar 22
Latest ownership filings
4
NAVEEN BHATIA
5 Apr 24
4
Eric Harold Yecies
25 Mar 24
4
MARIA E. STAN
25 Mar 24
4
Stefan Galluppi
25 Mar 24
4
Marc David Benathen
25 Mar 24
4
Nicholas P Alvarez
25 Mar 24
4
NAVEEN BHATIA
14 Mar 24
SC 13G/A
Divisadero Street Capital Management, LP
14 Feb 24
4
Justin Schreiber
15 Nov 23
4
Piyush Jindal
8 Nov 23
SC 13G
Divisadero Street Capital Management, LP
6 Oct 23
4/A
Bertrand Velge
1 Sep 23
4
Bertrand Velge
31 Aug 23
4
John R Strawn Jr
29 Aug 23
4
Roberto Simon
23 Aug 23
4
Alexander Mironov
1 Aug 23
4
Nicholas P Alvarez
13 Jul 23
4
Marc David Benathen
13 Jul 23
4
WILLIAM J FEBBO
22 Jun 23
3
WILLIAM J FEBBO
22 Jun 23
4
Eric Harold Yecies
16 Jun 23
4
NAVEEN BHATIA
16 Jun 23
4
Piyush Jindal
15 Jun 23
4
Brad Michael Roberts
15 Jun 23
4
Bertrand Velge
15 Jun 23
4
Nicholas P Alvarez
15 Jun 23
4
Bertrand Velge
14 Jun 23
4
Eric Harold Yecies
14 Jun 23
4
Bertrand Velge
7 Jun 23
4/A
Stefan Galluppi
31 May 23
4
Brad Michael Roberts
30 May 23
4
Justin Schreiber
24 May 23
4
Stefan Galluppi
23 May 23
4
JOAN LAROVERE
13 Feb 23
3
JOAN LAROVERE
13 Feb 23
5
Stefan Galluppi
6 Feb 23
4
JESSICA FRIEDEMAN
5 Jan 23
3
JESSICA FRIEDEMAN
5 Jan 23
4
Kathleen E Walsh
23 Dec 22
3
Kathleen E Walsh
23 Dec 22